摘要
颅内动脉粥样硬化(AS)是引起缺血性脑卒中的主要原因之一,各种外界因素、遗传因素及自身内环境的异常都与颅内AS的形成相关,其中较为重要的因素包括年龄、代谢综合征和血脂异常等。这些因素在导致颅内AS形成的过程中危险程度各有不同。在由AS引起的缺血性脑卒中的二级预防中,阿司匹林是最重要的抗血小板药物之一,但一些新的抗血小板药物在抗AS过程中的作用也值得关注。
Intracranial atherosclerotic disease(ICAD) is the most common proximate mechanism of ischemic stroke. Tbere are many risk factors associated with intracranial atherosclerosis, such as age, metabolic syndrome and dyslipidemia,whieh may cause different degrees of risks for ICAD. In terms of secondary prevention of stroke due to intracranial atherosclerotic stenosis, aspirin continues to be the preferred antiplatelet agent, while some new antiplatelet agents are also worth attention for their role of atheroselerosis resistance.
出处
《医学综述》
2013年第21期3932-3934,共3页
Medical Recapitulate
关键词
动脉粥样硬化
性别
代谢综合征
血脂
药物治疗
血管内治疗
Atherosclerosis
Gender
Metabolic syndrome
Blood tat
Drug therapy
Endovascu- lar therapy